Kristin Highland is a Respiratory physician affiliated with Cleveland Clinic. OpenAlex indexes 182 publications with 7,470 citations (h-index 39).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2049 E. 100th Street, Floor 11
Cleveland, OH 44106
Telephone
216-445-5429Provider last certified this registry record 24 May 2022.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year202585 payments$60,079openpaymentsdata.cms.gov ↗
- Actelion Pharmaceuticals US, Inc.Program year202537 payments$27,948openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202510 payments$15,136openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
26.8%Endothelin Receptor Antagonist13.4%Opsumit63%Ambrisentan28%Letairis9%Part D<11 patientsLoop diuretic3.9%Bumetanide47%Furosemide32%Torsemide21%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
17.9%Corticosteroid6.1%Prednisone100%Part D≥41 patientsProton pump inhibitor6%Omeprazole78%Pantoprazole Sodium22%Part D<11 patients+ 3 more classes in this area
Genitourinary & hormones
13%Phosphodiesterase 5 Inhibitor13%Sildenafil Citrate53%Tadalafil38%Adcirca9%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024 - Idiopathic inflammatory myopathies related lung disease in adults
The Lancet Respiratory Medicine
2024 - Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine
2023 - Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Arthur McCullough, MD
Cleveland Clinic
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”